Corneal inlay implantation complicated by XXXX .

@entity1 @entity227 @entity10818 @entity1036
BACKGROUND/AIMS: To report five cases of @entity1036 following corneal inlay implantation for the surgical correction of @entity10818 . METHODS: This was a retrospective, observational case series. Five eyes of five @entity1 were identified consecutively in two emergency departments during a 1-year period, from November 2013 to November 2014. @entity1 ' demographics, clinical features, treatment and outcomes are described. RESULTS: There were four female @entity1 and one male, aged 52-64   years. Three @entity1 had the KAMRA inlay (AcuFocus) and two had the Flexivue Microlens inlay (Presbia Co  peratief U.A.) inserted for the treatment of @entity10818 and they presented from 6   days to 4   months postoperatively. Presenting uncorrected vision ranged from 6/38 to counting fingers. One @entity1 's corneal scrapings were positive for a putatively causative organism, Corynebacterium pseudodiphtheriticum, and all @entity1 responded to broad-spectrum fortified topical antibiotics. All @entity1 lost vision with final uncorrected visual acuity ranging from 6/12 to 6/60 and best-corrected vision ranging from 6/7.5 to 6/12. Two @entity1 ' corneal inlays were explanted and three remained in situ at last follow-up. CONCLUSIONS: @entity1036 can occur at an early or late stage following corneal inlay implantation. Final visual acuity can be limited by stromal scarring; in the cases where the infiltrate was small and off the @entity227 at the time of presentation, the final visual acuity was better than those @entity1 who presented with larger lesions affecting the @entity227 . Though infection may necessitate removal of the inlay, early positive response to treatment may enable the inlay to be left in situ.
